Related Experiment Video
Updated: Aug 11, 2026
10:50
Primary Culture of Human Vestibular Schwannomas
Published on: July 20, 2014
Contiguous conventional and plexiform schwannomas. Report of two cases
J Bradley White1, Bernd W Scheithauer, Kimberly K Amrami
1Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota 55905, USA.
Journal of Neurosurgery
|March 3, 2006
Summary
This study reports the first case of conventional schwannoma alongside deep plexiform schwannoma in two adult patients. Differentiating these schwannomas is crucial for patient management and prognosis.
Area of Science:
- Neuropathology
- Oncology
- Radiology
Background:
- Schwannomas are nerve sheath tumors, with plexiform schwannomas being rare and often associated with neurofibromatosis type 2 (NF2).
- Distinguishing plexiform schwannomas from plexiform neurofibromas is critical due to the latter's association with neurofibromatosis type 1 (NF1) and malignant potential.
Observation:
- Two adult patients presented with distinct clinical, imaging, and histological features of a conventional schwannoma contiguous with a deep plexiform schwannoma.
- One patient had a history of neurofibromatosis type 2 (NF2) with multiple intracranial and intraspinal lesions; the other patient did not have NF2.
- Magnetic resonance imaging (MRI) revealed distinct features for both lesions in both patients.
Findings:
- The study identified the first reported instance of a conventional schwannoma contiguous with a deep plexiform schwannoma.
- Plexiform schwannomas, though rare, may be more common in neurofibromatosis type 2 patients than previously recognized.
- Pathological confirmation is essential for accurate diagnosis and to rule out plexiform neurofibromas.
Implications:
- This finding expands the understanding of schwannoma presentations, particularly in the context of NF2.
- Enhanced vigilance and diagnostic accuracy for plexiform schwannomas in NF2 patients are recommended.
- Accurate differentiation between schwannoma subtypes impacts treatment strategies and patient outcomes.
